Coronaphobia in Rheumatic Diseases

计划入组 60 人 · 首次发布于 2022 年 9 月 26 日

Nutrition in Rheumatic Diseases

计划入组 120 人 · 首次发布于 2020 年 10 月 14 日

Telerehabilitation in Rheumatic Diseases

计划入组 30 人 · 首次发布于 2022 年 8 月 9 日

Hydrocortisone succinate(Solu-cortef)

C₂₅H₃₄O₈

Methylprednisolone hemisuccinate(Solu-medrol)

C₂₆H₃₄O₈

SIG-XXX

HOKKAIDO MEDICAL CENTER FOR RHEUMATIC DISEASES

Japan

Aceragen

United States

RECORDATI RARE DISEASES

France

Kiel Laboratories Achieves 16th FDA Approval with Novel Excipient-Based Oral Suspension for Rheumatic Diseases

Pacira's Gene Therapy PCRX-201 Shows Durable Two-Year Benefit in Knee Osteoarthritis, Phase 1 Data Published in Annals of the Rheumatic Diseases

Viral Infections Emerge as Critical Consideration in Rheumatic Disease Management